| 标题 |
Cemiplimab monotherapy for first-line treatment of advanced non-small-cell lung cancer with PD-L1 of at least 50%: a multicentre, open-label, global, phase 3, randomised, controlled trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet 作者:Ahmet Sezer; Saadettin Kılıçkap; Mahmut Gümüş; Igor Bondarenko; Mustafa Özgüroğlu; et al 出版日期:2021-02-01 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)